Close Menu

NEW YORK (GenomeWeb) — The National Institutes of Health this week announced that it has earmarked $28 million over the next four years to fund the study and refinement of clinical measures of social impairment in autism spectrum disorder.

The effort, which is being led by Yale School of Medicine's James McPartland, is being supported under the Biomarkers Consortium, a research partnership of industry, government, and academic groups focused on identifying and validating biomarkers for a variety of diseases.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.